SCHEMBL25431389

SCHEMBL25431389

Cc1ccc(C=CC(=O)c2c(C)c3ccc(C)cc3[nH]c2=O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.61
▸ LMNA P02545 4/20 0.61
▸ HTT P42858 4/20 0.61
▸ NPSR1 Q6W5P4 3/20 0.61
▸ PADI4 Q9UM07 8/20 0.61
▸ MAPK10 P53779 1/20 0.53
▸ SLC5A1 P13866 1/20 0.50
▸ SLC5A2 P31639 1/20 0.50
▸ MAPT P10636 5/20 0.47
▸ ASAH1 Q13510 1/20 0.44
▸ CYP3A4 P08684 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2D6 P10635 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NPC1 O15118 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30590362 1.00 SMN1; SMN2 (0.61) SMN1; SMN2LMNAHTTNPSR1PADI4
SCHEMBL25431384 1.00 SMN1; SMN2 (0.61) SMN1; SMN2LMNAHTTNPSR1PADI4
SCHEMBL30590350 0.90 PADI4 (0.56) SMN1; SMN2LMNAHTTNPSR1PADI4
SCHEMBL25431797 0.90 PADI4 (0.56) SMN1; SMN2LMNAHTTNPSR1PADI4
SCHEMBL30590388 0.90 PADI4 (0.56) SMN1; SMN2LMNAHTTNPSR1PADI4
SCHEMBL25434718 0.90 PADI4 (0.56) SMN1; SMN2LMNAHTTNPSR1PADI4
SCHEMBL25434711 0.90 PADI4 (0.56) SMN1; SMN2LMNAHTTNPSR1PADI4
SCHEMBL25431794 0.90 PADI4 (0.56) SMN1; SMN2LMNAHTTNPSR1PADI4
SCHEMBL25434667 0.87 PADI4 (0.78) SMN1; SMN2LMNAHTTNPSR1PADI4
SCHEMBL25434661 0.87 PADI4 (0.78) SMN1; SMN2LMNAHTTNPSR1PADI4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4482831-A1 NOVEL BICYCLIC COMPOUNDS AS RAD51 INHIBITORS Satya Therapeutics, Inc. (US) 2025-01-01 — — EP disclosed
WO-2023161782-A1 NOVEL BICYCLIC COMPOUNDS AS RAD51 INHIBITORS SATYARX PHARMA INNOVATIONS PVT LTD (IN) 2023-08-31 — — WO disclosed
Send feedback